Trial Profile
Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Jan 2012
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 01 Dec 2011 Results published in the American Heart Journal.
- 02 Mar 2011 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 21 Sep 2010 Primary endpoint 'Myocardial-infarct-size' has not been met.